Pharmaleaders 2013 annual & historic platform 6th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2013 organized by Network 7 Media Group’s Pharmaleaders, Asia’s most analytical healthcare media will raise the issue of greater interaction, meaningful interaction & dialogue between the Indian Medical Practitioners & the drug makers in the branded formulation market said Satya Brahma in an interview to IANS. Of late we have seen the widening gap of interaction in the form of updating clinical & medical communications to the Doctors by the Pharma Companies leading to the erosion of values in medical profession. Traditionally the standard practice of detailing to the doctors has been to update the doctors by the pharma companies through communication materials such as visual ads, product informations, new & research product launches. Doctors look at Medical Representatives as the tool to update their knowledge in latest breakthrough in medical research & look at the Pharma Companies as the reliable partner of their medical practice who reach out to them to get an endorsement of the product baskets.
FDI Policy, Clinical Trial Approvals, Compulsive licensing & the slowdown in the number of new product launches, regulatory challenges, the hostile economic environment in India, Drug Prices Control Order (DPCO) 2013 of lowering the prices of 348 essential drugs are some of the biggest challenges & worries for the leading Indian pharma companies seem to indicate that the lack of interest in staying in business leading to the wider concentration on reaching out to the doctors.
“There is widespread report of an unholy nexus between the doctors & the pharma companies in cementing commercial deals are distressing & is increasing rapidly in india despite MCI guidelines. Give & Take seem to be the order of the day resulting in the erosion of ethics in medical profession. It is widely believed that pharma companies & doctors are engaged in dubious commercial transactions as pharma companies feel that doctors have multiple options available to endorse the products in regular product basket unless the pharma company has something new to offer which compel the doctors to prescribe. This is the focal point at the Summit as we attempt to bring face to face with the drug companies & doctors in the single platform said” Satya Brahma
Pharmaleaders believe that though the entire scenario is not the same as doctors & pharma companies know that it is only the research driven products & efficacy in drugs are key but the large portion of the market need to increase the interaction on strong medical values & ethics in profession. Entering in its 6th Year, the much anticipated & awaited prestigious title is attempting to revisit the current state of medical profession & the pressure of building brands & most importantly, maintaining the sustainable growth record in an era where Government’s policy making machine making a difficult task to the thinking process & the strategies to retain market dominance. As Pharmaleaders march ahead to host the event, both domestic & international markets have been witnessing a change of approach. Indian pharmaceutical industry is globally ranked fourth in terms of volume, constituting 8% of total world’s production. Its value is estimated at $17 billion. India is now among the top five pharmaceutical emerging markets globally.The industry is expected to touch US$ 35.9 billion by 2016.
Pharmaleaders has padded some of the biggest names in the pharmaceutical & medical profession to debate on the wide ranging issues under the theme Incredible Pharmaleaders, Billion Dreams – Pushing India’s Growth on 27th December in Mumbai in india. Amongst the leaders who will address are Mr. Kewal Kanda,Promoter Director,Salus Lifecare Pvt Ltd on Decoding the success mantra of Indian Pharma Industry in an era of Govt regulations, Dr Mukesh Batra, Founder Chairman, Dr Batra's Positive Health Clinic, on Challenges of Globalizing Homeopathic Medicines : A Dr Batra's Case Study, Mr.Mahesh Zagade, Commissioner FDA, Maharashtra, Government of Maharashtra on Regulatory Challenges of Indian Plants. FDA Initiative to curb counterfeit drugs, Dr Shasank. R. Joshi ,Consulting Endocrinologist & Diabetologist on The Evolving Profile of the Indian Medical Practitioners : Doctors Expectations from the Pharmaceutical Companies - Beyond Gifts & Vacation Sponsorships, Mr. Deepak Naik,Managing Director, Health 'N' U Therapeutics Pvt. Ltd on Has the Pharmaceutical Companies failed to impress the doctors on medical education by adopting unethical means?, Dr.GSK Velu, Founder Chairman, Trivitron Group of Companies on Challenges & Oppourtunities of Indian Medical Device Industry, Dr Naresh Trehan, Cardiovascular and Cardiothoracic Surgeon & CMDS,Medanta on Making of India's Leadership in Medical Innovation : The Real Time Experience, Dr. Shuba Dharmana, Cosmetic Dermatologist & Founder CEO, Le'jeune Medspa on The Changing Face of Indian Skincare Innovations, Prof. Dr. Nandkishore Shamrao Laud, Founder, Dr Laud Clinic on Cost effective Healthcare through citizens community participation.S. Krishnakumar of Future Steps will moderate the event. Dr. Kancherla Ravindranath, CMD, Global Hospitals Group, Dr. Kaushal Pandey, Cardiac Surgeon, Dr. Sudhir Vaishnav, Interventional Cardiologist, Dr Deepak K Jhumani, Consultant in Sexual Health and Counsellor, Dr. Harish S. Bhende Orthopaedic Surgeon, Dr. Chytra v Anand, Founder&
6th Annual Pharmaceutical Leadership Summit 2013 will also felicitate the top doctors & pharma companies in 40 categories in a glittering award night.